Salarius Investments vs Stock Based Compensation Analysis

SLRX Stock

USD 1.52 0.15 10.95%

Salarius Pharmaceuticals financial indicator trend analysis is much more than just breaking down Salarius Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Salarius Pharmaceuticals is a good investment. Please check the relationship between Salarius Pharmaceuticals Investments and its Stock Based Compensation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Salarius Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Salarius Stock please use our How to Invest in Salarius Pharmaceuticals guide.

Investments vs Stock Based Compensation

Investments vs Stock Based Compensation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Salarius Pharmaceuticals Investments account and Stock Based Compensation. At this time, the significance of the direction appears to have pay attention.

The correlation between Salarius Pharmaceuticals' Investments and Stock Based Compensation is -0.73. Overlapping area represents the amount of variation of Investments that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Salarius Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Salarius Pharmaceuticals' Investments and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of Salarius Pharmaceuticals are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Investments i.e., Salarius Pharmaceuticals' Investments and Stock Based Compensation go up and down completely randomly.

Correlation Coefficient

-0.73

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most indicators from Salarius Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Salarius Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Salarius Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Salarius Stock please use our How to Invest in Salarius Pharmaceuticals guide.Issuance Of Capital Stock is likely to rise to about 10.1 M in 2024, whereas Selling General Administrative is likely to drop 5,435 in 2024.

	2023	2024 (projected)
Depreciation And Amortization	10.05	9.55
Interest Income	355.8K	441.7K

Depreciation And Amortization Interest Income

Salarius Pharmaceuticals fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Net Tangible Assets	Other Assets	Retained Earnings Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Deferred Long Term Liab
Total Assets		0.36	0.13	0.74	0.75	-0.87	0.24	0.39	0.87	-0.07	-0.36	0.98	-0.14	0.09	0.21	-0.13	0.11	0.75	0.99	0.26	0.46	0.11	-0.35	-0.51	0.52	0.43
Other Current Liab	0.36		0.01	0.43	-0.01	-0.47	0.04	-0.02	0.47	-0.15	-0.61	0.37	0.17	-0.18	0.16	-0.16	-0.19	-0.01	0.38	-0.02	0.25	0.03	-0.28	0.07	-0.06	0.09
Total Current Liabilities	0.13	0.01		0.51	0.47	0.22	-0.43	0.91	-0.22	0.07	-0.42	0.1	0.45	-0.64	0.72	0.57	-0.59	0.48	0.12	0.26	-0.61	-0.09	0.64	0.03	-0.16	0.09
Total Stockholder Equity	0.74	0.43	0.51		0.71	-0.41	-0.25	0.58	0.41	0.1	-0.7	0.69	0.45	-0.61	0.69	0.39	-0.58	0.72	0.71	0.56	-0.2	0.2	0.25	-0.1	0.06	0.16
Property Plant And Equipment Net	0.75	-0.01	0.47	0.71		-0.43	-0.26	0.71	0.43	-0.32	-0.45	0.78	0.02	-0.18	0.28	0.39	-0.14	1.0	0.78	0.16	-0.04	-0.23	0.13	-0.45	0.58	0.27
Net Debt	-0.87	-0.47	0.22	-0.41	-0.43		-0.43	-0.07	-1.0	0.18	0.16	-0.89	0.38	-0.44	0.16	0.44	-0.45	-0.42	-0.88	-0.05	-0.8	-0.14	0.72	0.49	-0.6	-0.4
Retained Earnings	0.24	0.04	-0.43	-0.25	-0.26	-0.43		-0.41	0.44	0.4	0.41	0.17	-0.62	0.66	-0.16	-0.94	0.65	-0.28	0.17	-0.23	0.72	0.12	-0.68	-0.3	-0.05	0.31
Accounts Payable	0.39	-0.02	0.91	0.58	0.71	-0.07	-0.41		0.07	-0.08	-0.38	0.37	0.3	-0.44	0.51	0.55	-0.38	0.71	0.39	0.3	-0.4	-0.09	0.48	-0.27	0.23	0.34
Cash	0.87	0.47	-0.22	0.41	0.43	-1.0	0.44	0.07		-0.18	-0.16	0.89	-0.38	0.44	-0.16	-0.45	0.45	0.42	0.88	0.05	0.8	0.14	-0.72	-0.5	0.59	0.41
Non Current Assets Total	-0.07	-0.15	0.07	0.1	-0.32	0.18	0.4	-0.08	-0.18		0.28	-0.24	0.12	-0.22	0.45	-0.19	-0.23	-0.33	-0.23	0.58	-0.2	0.62	0.28	-0.05	-0.55	0.25
Non Currrent Assets Other	-0.36	-0.61	-0.42	-0.7	-0.45	0.16	0.41	-0.38	-0.16	0.28		-0.38	-0.4	0.6	-0.45	-0.34	0.59	-0.46	-0.4	-0.01	0.24	0.39	-0.19	-0.09	0.02	0.16
Cash And Short Term Investments	0.98	0.37	0.1	0.69	0.78	-0.89	0.17	0.37	0.89	-0.24	-0.38		-0.18	0.14	0.11	-0.1	0.17	0.78	1.0	0.15	0.49	0.01	-0.4	-0.49	0.61	0.37
Common Stock Total Equity	-0.14	0.17	0.45	0.45	0.02	0.38	-0.62	0.3	-0.38	0.12	-0.4	-0.18		-0.84	0.57	0.69	-0.84	0.04	-0.16	0.56	-0.71	0.29	0.62	0.6	-0.49	-0.25
Non Current Liabilities Total	0.09	-0.18	-0.64	-0.61	-0.18	-0.44	0.66	-0.44	0.44	-0.22	0.6	0.14	-0.84		-0.78	-0.75	1.0	-0.2	0.12	-0.52	0.85	-0.14	-0.81	-0.43	0.51	0.26
Other Current Assets	0.21	0.16	0.72	0.69	0.28	0.16	-0.16	0.51	-0.16	0.45	-0.45	0.11	0.57	-0.78		0.36	-0.76	0.3	0.14	0.48	-0.56	0.25	0.56	0.32	-0.58	-0.15
Other Stockholder Equity	-0.13	-0.16	0.57	0.39	0.39	0.44	-0.94	0.55	-0.45	-0.19	-0.34	-0.1	0.69	-0.75	0.36		-0.74	0.4	-0.1	0.43	-0.82	0.03	0.82	0.25	-0.02	-0.19
Total Liab	0.11	-0.19	-0.59	-0.58	-0.14	-0.45	0.65	-0.38	0.45	-0.23	0.59	0.17	-0.84	1.0	-0.76	-0.74		-0.16	0.15	-0.52	0.84	-0.15	-0.8	-0.47	0.54	0.29
Property Plant And Equipment Gross	0.75	-0.01	0.48	0.72	1.0	-0.42	-0.28	0.71	0.42	-0.33	-0.46	0.78	0.04	-0.2	0.3	0.4	-0.16		0.78	0.17	-0.05	-0.22	0.14	-0.42	0.56	0.25
Total Current Assets	0.99	0.38	0.12	0.71	0.78	-0.88	0.17	0.39	0.88	-0.23	-0.4	1.0	-0.16	0.12	0.14	-0.1	0.15	0.78		0.16	0.48	0.01	-0.39	-0.49	0.6	0.38
Common Stock	0.26	-0.02	0.26	0.56	0.16	-0.05	-0.23	0.3	0.05	0.58	-0.01	0.15	0.56	-0.52	0.48	0.43	-0.52	0.17	0.16		-0.36	0.8	0.45	-0.01	-0.14	0.22
Net Tangible Assets	0.46	0.25	-0.61	-0.2	-0.04	-0.8	0.72	-0.4	0.8	-0.2	0.24	0.49	-0.71	0.85	-0.56	-0.82	0.84	-0.05	0.48	-0.36		-0.02	-0.97	-0.41	0.5	0.26
Other Assets	0.11	0.03	-0.09	0.2	-0.23	-0.14	0.12	-0.09	0.14	0.62	0.39	0.01	0.29	-0.14	0.25	0.03	-0.15	-0.22	0.01	0.8	-0.02		0.09	0.13	-0.25	0.18
Retained Earnings Total Equity	-0.35	-0.28	0.64	0.25	0.13	0.72	-0.68	0.48	-0.72	0.28	-0.19	-0.4	0.62	-0.81	0.56	0.82	-0.8	0.14	-0.39	0.45	-0.97	0.09		0.21	-0.38	-0.07
Common Stock Shares Outstanding	-0.51	0.07	0.03	-0.1	-0.45	0.49	-0.3	-0.27	-0.5	-0.05	-0.09	-0.49	0.6	-0.43	0.32	0.25	-0.47	-0.42	-0.49	-0.01	-0.41	0.13	0.21		-0.73	-0.81
Capital Surpluse	0.52	-0.06	-0.16	0.06	0.58	-0.6	-0.05	0.23	0.59	-0.55	0.02	0.61	-0.49	0.51	-0.58	-0.02	0.54	0.56	0.6	-0.14	0.5	-0.25	-0.38	-0.73		0.45
Deferred Long Term Liab	0.43	0.09	0.09	0.16	0.27	-0.4	0.31	0.34	0.41	0.25	0.16	0.37	-0.25	0.26	-0.15	-0.19	0.29	0.25	0.38	0.22	0.26	0.18	-0.07	-0.81	0.45

Click cells to compare fundamentals

Salarius Pharmaceuticals Account Relationship Matchups

Salarius Pharmaceuticals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	13.9M	24.9M	40.8M	14.7M	6.6M	6.3M
Other Current Liab	478.5K	442.3K	567.8K	1.4M	406.7K	532.5K
Total Current Liabilities	3.3M	2.8M	2.1M	4.3M	1.3M	2.3M
Total Stockholder Equity	10.6M	22.2M	38.7M	10.4M	5.3M	5.0M
Property Plant And Equipment Net	74K	25.0K	22.6K	7.9K	7.1K	6.7K
Net Debt	(3.2M)	(10.6M)	(29.2M)	(12.1M)	(5.6M)	(5.9M)
Retained Earnings	(12.1M)	(19.4M)	(32.2M)	(63.8M)	(76.3M)	(80.2M)
Accounts Payable	1.8M	1.9M	1.5M	2.9M	602.9K	572.7K
Cash	3.7M	11.1M	29.2M	12.1M	5.9M	5.6M
Non Current Assets Total	9.2M	9.1M	10.7M	130.5K	66.9K	63.5K
Non Currrent Assets Other	308.7K	247.1K	1.8M	130.5K	66.9K	63.5K
Cash And Short Term Investments	3.7M	11.1M	29.2M	12.1M	5.9M	5.6M
Common Stock Total Equity	1.8K	1.8K	451.0	2.4K	2.7K	1.6K
Liabilities And Stockholders Equity	13.9M	24.9M	40.8M	14.7M	6.6M	6.3M
Non Current Liabilities Total	980.9K	919.4K	567.8K	1.4M	406.7K	386.4K
Other Current Assets	955.9K	822.1K	949.2K	803.4K	619.8K	816.3K
Other Stockholder Equity	22.7M	41.6M	70.9M	74.2M	81.6M	82.0M
Total Liab	3.3M	2.8M	2.1M	4.3M	1.3M	1.2M
Property Plant And Equipment Gross	331.0K	74.5K	25.0K	22.6K	20.4K	19.4K
Total Current Assets	4.7M	15.8M	30.2M	14.5M	6.5M	6.2M
Common Stock	451.0	2.4K	4.5K	225.0	393.0	373.35
Net Tangible Assets	1.7M	13.3M	29.9M	10.4M	9.3M	14.2M
Other Assets	0.0	247.1K	1.8M	130.5K	1.0	0.95
Common Stock Shares Outstanding	130.7K	623.1K	1.7M	2.1M	3.3M	3.4M
Capital Surpluse	140.2M	142.2M	22.7M	41.6M	37.4M	35.6M
Property Plant Equipment	37.5K	25.0K	22.6K	7.9K	7.1K	6.7K
Inventory	432K	187K	0.0	(1.6M)	(1.4M)	(1.4M)
Net Invested Capital	11.1M	22.6M	38.7M	10.4M	5.6M	5.3M
Net Working Capital	1.4M	13.0M	28.1M	10.3M	5.2M	5.0M
Capital Stock	451.0	2.4K	4.5K	225.0	393.0	373.35

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Salarius Stock Analysis

When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Salarius Investments vs Stock Based Compensation Analysis

Investments vs Stock Based Compensation

Investments vs Stock Based Compensation Correlation Analysis

Correlation Coefficient

Investments

Stock Based Compensation

Salarius Pharmaceuticals fundamental ratios Correlations

Salarius Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Salarius Pharmaceuticals fundamental ratios Accounts

Also Currently Popular

Additional Tools for Salarius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 1.0	Non Current Liabilities Total
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.98	Total Assets
Accounts Payable	+ 0.91	Total Current Liabilities

Cash	- 1.0	Net Debt
Retained Earnings Total Equity	- 0.97	Net Tangible Assets
Other Stockholder Equity	- 0.94	Retained Earnings
Cash And Short Term Investments	- 0.89	Net Debt
Total Current Assets	- 0.88	Net Debt
Net Debt	- 0.87	Total Assets